Loading clinical trials...
Loading clinical trials...
A Clinical Study of Pharmacokinetics, Efficacy and Safety of Vaginal Application of Lyophilised Lactobacilli and 0.03 mg Estriol (Gynoflor®) on Atrophic Vaginitis in Postmenopausal Breast Cancer Patients Treated With Aromatase Inhibitors
Conditions
Interventions
Estriol 0.03 mg, lyophylized lactobacillus
Locations
2
Belgium
University Hospital Leuven
Leuven, Belgium
Department of Obstetrics and Gynaecology, University of Regensburg
Regensburg, Germany
Start Date
April 1, 2011
Primary Completion Date
July 1, 2012
Completion Date
July 1, 2012
Last Updated
October 15, 2024
NCT04045379
NCT00984399
NCT04219605
NCT06808347
NCT02460302
NCT02195986
Lead Sponsor
Medinova AG
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions